IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-53047-1.html
   My bibliography  Save this article

Valence-engineered catalysis-selectivity regulation of molybdenum oxide nanozyme for acute kidney injury therapy and post-cure assessment

Author

Listed:
  • Liangyu Li

    (Beijing University of Chemical Technology)

  • Xiaotong Liu

    (Beijing University of Chemical Technology)

  • Guanghe Liu

    (Beijing University of Chemical Technology)

  • Suying Xu

    (Beijing University of Chemical Technology)

  • Gaofei Hu

    (Beijing University of Chemical Technology)

  • Leyu Wang

    (Beijing University of Chemical Technology)

Abstract

The optimization of the enzyme-like catalytic selectivity of nanozymes for specific reactive oxygen species (ROS)-related applications is significant, and meanwhile the real-time monitoring of ROS is really crucial for tracking the therapeutic process. Herein, we present a mild oxidation valence-engineering strategy to modulate the valence states of Mo in Pluronic F127-coated MoO3-x nanozymes (denoted as MF-x, x: oxidation time) in a controlled manner aiming to improve their specificity of H2O2-associated catalytic reactions for specific therapy and monitoring of ROS-related diseases. Experimentally, MF-0 (Mo average valence 4.64) and MF-10 (Mo average valence 5.68) exhibit exclusively optimal catalase (CAT)- or peroxidase (POD)-like activity, respectively. Density functional theory (DFT) calculations verify the most favorable reaction path for both MF-0- and MF-10-catalyzed reaction processes based on free energy diagram and electronic structure analysis, disclosing the mechanism of the H2O2 activation pathway on the Mo-based nanozymes. Furthermore, MF-0 poses a strong potential in acute kidney injury (AKI) treatment, achieving excellent therapeutic outcomes in vitro and in vivo. Notably, the ROS-responsive photoacoustic imaging (PAI) signal of MF-0 during treatment guarantees real-time monitoring of the therapeutic effect and post-cure assessment in vivo, providing a highly desirable non-invasive diagnostic approach for ROS-related diseases.

Suggested Citation

  • Liangyu Li & Xiaotong Liu & Guanghe Liu & Suying Xu & Gaofei Hu & Leyu Wang, 2024. "Valence-engineered catalysis-selectivity regulation of molybdenum oxide nanozyme for acute kidney injury therapy and post-cure assessment," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
  • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-53047-1
    DOI: 10.1038/s41467-024-53047-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-53047-1
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-024-53047-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Qinjie Weng & Heng Sun & Chunyan Fang & Fan Xia & Hongwei Liao & Jiyoung Lee & Jincheng Wang & An Xie & Jiafeng Ren & Xia Guo & Fangyuan Li & Bo Yang & Daishun Ling, 2021. "Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics," Nature Communications, Nature, vol. 12(1), pages 1-14, December.
    2. Tengfei Liu & Bowen Xiao & Fei Xiang & Jianglin Tan & Zhuo Chen & Xiaorong Zhang & Chengzhou Wu & Zhengwei Mao & Gaoxing Luo & Xiaoyuan Chen & Jun Deng, 2020. "Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases," Nature Communications, Nature, vol. 11(1), pages 1-16, December.
    3. Ge Fang & Weifeng Li & Xiaomei Shen & Jose Manuel Perez-Aguilar & Yu Chong & Xingfa Gao & Zhifang Chai & Chunying Chen & Cuicui Ge & Ruhong Zhou, 2018. "Differential Pd-nanocrystal facets demonstrate distinct antibacterial activity against Gram-positive and Gram-negative bacteria," Nature Communications, Nature, vol. 9(1), pages 1-9, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Chi Yao & Yuwei Xu & Jianpu Tang & Pin Hu & Hedong Qi & Dayong Yang, 2022. "Dynamic assembly of DNA-ceria nanocomplex in living cells generates artificial peroxisome," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    2. Mingru Bai & Ting Wang & Zhenyu Xing & Haoju Huang & Xizheng Wu & Mohsen Adeli & Mao Wang & Xianglong Han & Ling Ye & Chong Cheng, 2024. "Electron-donable heterojunctions with synergetic Ru-Cu pair sites for biocatalytic microenvironment modulations in inflammatory mandible defects," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
    3. Jie Cai & Jie Peng & Juan Feng & Ruocheng Li & Peng Ren & Xinwei Zang & Zezong Wu & Yi Lu & Lin Luo & Zhenzhen Hu & Jiaying Wang & Xiaomeng Dai & Peng Zhao & Juan Wang & Mi Yan & Jianxin Liu & Renren , 2023. "Antioxidant hepatic lipid metabolism can be promoted by orally administered inorganic nanoparticles," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    4. Biao Huang & Tao Tang & Shi-Hui Chen & Hao Li & Zhi-Jun Sun & Zhi-Lin Zhang & Mingxi Zhang & Ran Cui, 2023. "Near-infrared-IIb emitting single-atom catalyst for imaging-guided therapy of blood-brain barrier breakdown after traumatic brain injury," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    5. Lu Peng & Haojie Zhu & Haobin Wang & Zhenbin Guo & Qianyuan Wu & Cheng Yang & Hong-Ying Hu, 2023. "Hydrodynamic tearing of bacteria on nanotips for sustainable water disinfection," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    6. Songjing Zhong & Zeyu Zhang & Qinyu Zhao & Zhaoyang Yue & Cheng Xiong & Genglin Chen & Jie Wang & Linlin Li, 2024. "Lattice expansion in ruthenium nanozymes improves catalytic activity and electro-responsiveness for boosting cancer therapy," Nature Communications, Nature, vol. 15(1), pages 1-13, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-53047-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.